Effect of Potato Fiber on Appetite and Fecal Fat Excretion
NCT ID: NCT02957318
Last Updated: 2017-09-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
18 participants
INTERVENTIONAL
2016-09-30
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Aim: The aim of the study is to investigate the potential of 3-weeks daily intake of potato pulp (FiberBind), rhamnogalacturonan I isolated potato fiber (RG-I) vs. a low-fiber control (placebo) on satiety and fecal fat excretion in healthy adults. Furthermore, a number of secondary endpoints are investigated.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Potato Fiber and Gastrointestinal Function: Phase 3
NCT01964599
Enhanced Satiety With Pork Products Containing Dietary Fibre
NCT02521805
Effects of CharcoCapsĀ® (Activated Charcoal) vs. Placebo on Intestinal Gas Production
NCT05510778
The Effect of Dietary Fiber on Food Liking
NCT03241238
Comparison of Low GI and High GI Potatoes in Relation to Satiety (POSAT)
NCT03512509
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FiberBind
FiberBind
Potato pulp consisting of 68% fiber (5.5 soluble, 76.7% insoluble and 17.8% resistant starch), 9.7% water, 0.3% fat, 7.2% protein and 14% carbohydrates (starch).
RG-I fiber
RG-I fiber
Soluble fiber extracted from potato pulp consisting of 95% fiber and 5% water.
Placebo
Placebo
Low-fiber control
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FiberBind
Potato pulp consisting of 68% fiber (5.5 soluble, 76.7% insoluble and 17.8% resistant starch), 9.7% water, 0.3% fat, 7.2% protein and 14% carbohydrates (starch).
RG-I fiber
Soluble fiber extracted from potato pulp consisting of 95% fiber and 5% water.
Placebo
Low-fiber control
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI between 18.5 and 27.0 kg/m2
* Age 20-40 years
Exclusion Criteria
* Chronic diseases (known diabetes, cardiovascular disease, irritable bowels disease, colitis ulcerosa, crohn disease, or other chronic diseases which could affect the results of the present study)
* Gluten allergy
* Use of daily prescription medicine (mild analgesics are allowed)
* Use of lipid-lowering agents (e.g. Becel, HUSK)
* Use of food supplements of relevance to the study (such as pre- and probiotics)
* Irregular intake of vitamin /mineral supplements (two weeks prior to and during the entire study period)
* Smoking
* Elite athletes (\>10 hours of strenuous physical activity per week)
* Blood donation (\<1 month before study commencement and during study period)
* Participation in other clinical studies (\<1 month before study commencement and during study period)
* Inability (physically or psychologically) to comply with the procedures required by the protocol judged by the Investigator
20 Years
40 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anne Birgitte Raben
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Copenhagen, Department of Nutrition, Exercise and Sports
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B 326
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.